Skip to main content
Top
Published in: BMC Nephrology 1/2011

Open Access 01-12-2011 | Research article

Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series

Authors: Giorgina B Piccoli, Vincenzo Arena, Valentina Consiglio, Maria Chiara Deagostini, Ettore Pelosi, Anastasios Douroukas, Daniele Penna, Giancarlo Cortese

Published in: BMC Nephrology | Issue 1/2011

Login to get access

Abstract

Background

Intracystic infection, in Autosomal Dominant Polycystic Kidney Disease (ADPKD) and in kidneys with multiple cysts, is a diagnostic and therapeutic challenge, as conventional imaging techniques may not discriminate among "complicated" cysts (infection, bleeding, neoplasia), and as the clinical picture may be attenuated, in particular in early phases. Positron Emission Tomography with fluorodeoxyglucose (FDG-PET) was recently suggested as a tool to detect infection in ADPKD, in single cases and small series.
The aim of the study was to report on the role of FDG-PET in the work-up of 10 cases of suspected cystic infections, affected by ADPKD or with multiple kidney cysts.

Methods

Observational study. Review of clinical charts and of the imaging data since the use of FDG-PET for detecting cystic infections (2008-2010).

Results

In 2008-2010, 6 patients with ADPKD and 4 with multiple kidney cysts were referred for suspected intracystic infections (3 males, 7 females, aged 55-83 years, in all CKD stages); in one case the imaging was done in the work-up of a complicated "uremic" cyst. The clinical picture, the usual inflammatory markers and/or the conventional imaging techniques did not allow conclusive diagnosis at referral or during follow-up (ultrasounds in all, CT in 8/10). Nine patients displayed inflammatory signs (increase in C-reactive protein and other biochemical markers) and constitutional symptoms (fever in 9/10).
FDG-PET was positive in 6 cases (5 kidney and 1 liver cyst), was repeated during follow-up in 4 patients and was negative in 4 cases. In the positive cases, FDG-PET guided the therapeutic choices; in particular, the duration of therapy was supported by imaging data in the 4 cases with multiple scans. No relapse was recorded after discontinuation of antibiotic therapy in the treated patients. The negative cases did not develop clinical signs of cystic infection over follow-up.

Conclusion

In this case series, the largest prospective one so far published and the only one including different types of renal cysts, FDG-PET is confirmed as a promising diagnostic tool for detecting intracystic infection in ADPKD and in multiple kidney cysts, and a potential guide for tailoring therapy. Further larger and multicenter studies are needed to evaluate the cost-benefit ratio and the limits of this imaging technique in the clinical setting.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference Sallèe M, Rafat C, Zahar J, Paulmier B, Grunfeld JP, Knebelmann P, Fakhouri F: Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2009, 4: 1183-1189. 10.2215/CJN.01870309.CrossRefPubMedPubMedCentral Sallèe M, Rafat C, Zahar J, Paulmier B, Grunfeld JP, Knebelmann P, Fakhouri F: Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2009, 4: 1183-1189. 10.2215/CJN.01870309.CrossRefPubMedPubMedCentral
4.
go back to reference Levine E, Cook LT, Grantham JJ: Liver cysts in autosomal dominant polycystic kidney disease: clinical and computed tomography study. Am J Roentgenol. 1985, 145: 229-33.CrossRef Levine E, Cook LT, Grantham JJ: Liver cysts in autosomal dominant polycystic kidney disease: clinical and computed tomography study. Am J Roentgenol. 1985, 145: 229-33.CrossRef
5.
go back to reference Gibson P, Watson M: Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant. 1998, 13: 2455-7. 10.1093/ndt/13.10.2455.CrossRefPubMed Gibson P, Watson M: Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant. 1998, 13: 2455-7. 10.1093/ndt/13.10.2455.CrossRefPubMed
6.
go back to reference Chaveau D, Fakhouri F, Grunfeld JP: Liver involvement in autosomal dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol. 2000, 11: 1767-75. Chaveau D, Fakhouri F, Grunfeld JP: Liver involvement in autosomal dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol. 2000, 11: 1767-75.
7.
go back to reference Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet. 2007, 369: 1287-1301. 10.1016/S0140-6736(07)60601-1.CrossRefPubMed Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet. 2007, 369: 1287-1301. 10.1016/S0140-6736(07)60601-1.CrossRefPubMed
8.
go back to reference Levine E, Slusher SL, Grantham JJ, Wetzel LH: Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. Am J Roentgenol. 1991, 156 (3): 501-6.CrossRef Levine E, Slusher SL, Grantham JJ, Wetzel LH: Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. Am J Roentgenol. 1991, 156 (3): 501-6.CrossRef
9.
go back to reference Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M, Honda R: Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol. 2003, 59 (3): 153-9.CrossRefPubMed Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M, Honda R: Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol. 2003, 59 (3): 153-9.CrossRefPubMed
10.
go back to reference Amesur P, Castronuovo JJ, Chandramouly B: Infected cyst localization with gallium SPECT imaging in polycystic kidney disease. Clin Nucl Med. 1988, 13 (1): 35-7. 10.1097/00003072-198801000-00010.CrossRefPubMed Amesur P, Castronuovo JJ, Chandramouly B: Infected cyst localization with gallium SPECT imaging in polycystic kidney disease. Clin Nucl Med. 1988, 13 (1): 35-7. 10.1097/00003072-198801000-00010.CrossRefPubMed
11.
go back to reference Lahiri SA, Halff GA, Speeg KV, Esterl RM: In-111 WBC scan localizes infected hepatic cysts and confirms their complete resection in adult polycystic kidney disease. Clin Nucl Med. 1998, 23: 33-4. 10.1097/00003072-199801000-00010.CrossRefPubMed Lahiri SA, Halff GA, Speeg KV, Esterl RM: In-111 WBC scan localizes infected hepatic cysts and confirms their complete resection in adult polycystic kidney disease. Clin Nucl Med. 1998, 23: 33-4. 10.1097/00003072-199801000-00010.CrossRefPubMed
12.
go back to reference Tsang V, Lui S, Hilson A, Moorhead J, Fernando O, Sweny P: Gallium-67 scintigraphy in the detection of infected polycystic kidneys in renal transplant recipients. Nucl Med Commun. 1989, 10: 167-70. 10.1097/00006231-198903000-00008.CrossRefPubMed Tsang V, Lui S, Hilson A, Moorhead J, Fernando O, Sweny P: Gallium-67 scintigraphy in the detection of infected polycystic kidneys in renal transplant recipients. Nucl Med Commun. 1989, 10: 167-70. 10.1097/00006231-198903000-00008.CrossRefPubMed
13.
go back to reference Palestro CJ, Love C, Bhargava KK: Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging. 2009, 53: 105-23.PubMed Palestro CJ, Love C, Bhargava KK: Labeled leukocyte imaging: current status and future directions. Q J Nucl Med Mol Imaging. 2009, 53: 105-23.PubMed
14.
go back to reference Kaim AH, Burger C, Ganter CC, Goerres GW, Kamel E, Weishaupt D, Dizendorf E, Schaffner A, von Schulthess GK: PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report. Radiology. 2001, 221: 818-21. 10.1148/radiol.2213010445.CrossRefPubMed Kaim AH, Burger C, Ganter CC, Goerres GW, Kamel E, Weishaupt D, Dizendorf E, Schaffner A, von Schulthess GK: PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report. Radiology. 2001, 221: 818-21. 10.1148/radiol.2213010445.CrossRefPubMed
15.
go back to reference Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ: Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2003, 41: E18-21. 10.1016/S0272-6386(03)00368-8.CrossRefPubMed Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ: Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2003, 41: E18-21. 10.1016/S0272-6386(03)00368-8.CrossRefPubMed
16.
go back to reference Soussan M, Sberro R, Wartski M, Fakhouri F, Pecking AP, Alberini JL: Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease. Ann Nucl Med. 2008, 22: 529-31. 10.1007/s12149-008-0150-3.CrossRefPubMed Soussan M, Sberro R, Wartski M, Fakhouri F, Pecking AP, Alberini JL: Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease. Ann Nucl Med. 2008, 22: 529-31. 10.1007/s12149-008-0150-3.CrossRefPubMed
17.
go back to reference DeSouza RM, Prachalias A, Srinivasan P, O'Doherty M, Olsburgh J: Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management. Transplant Proc. 2009, 41: 1942-5. 10.1016/j.transproceed.2008.10.102.CrossRefPubMed DeSouza RM, Prachalias A, Srinivasan P, O'Doherty M, Olsburgh J: Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management. Transplant Proc. 2009, 41: 1942-5. 10.1016/j.transproceed.2008.10.102.CrossRefPubMed
18.
go back to reference Jumenez Bonilla JF, Quirce R, Calabia ER, Banzo I, Martinez-Rodriguez I, Carril JM: Hepatorenal polycystic disease and fever: diagnostic contribution of Gallium Citrate Ga 67 scan and fluorine F18 FDG-PET/CT. Eur Urol. 2009, Available online 8 June 2009 Jumenez Bonilla JF, Quirce R, Calabia ER, Banzo I, Martinez-Rodriguez I, Carril JM: Hepatorenal polycystic disease and fever: diagnostic contribution of Gallium Citrate Ga 67 scan and fluorine F18 FDG-PET/CT. Eur Urol. 2009, Available online 8 June 2009
19.
go back to reference Bleeker Rovers CP, Corstens FHM, Van Der Meer JVM, Oyen WJG: Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004, 31: 1342-1344.CrossRefPubMed Bleeker Rovers CP, Corstens FHM, Van Der Meer JVM, Oyen WJG: Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004, 31: 1342-1344.CrossRefPubMed
20.
go back to reference Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W: Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000, 27: 1617-25. 10.1007/s002590000341.CrossRefPubMed Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W: Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000, 27: 1617-25. 10.1007/s002590000341.CrossRefPubMed
21.
go back to reference Keidar Z, Gurman-Balbir A, Gaitini D, Israel O: Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008, 49: 1980-5. 10.2967/jnumed.108.054692.CrossRefPubMed Keidar Z, Gurman-Balbir A, Gaitini D, Israel O: Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008, 49: 1980-5. 10.2967/jnumed.108.054692.CrossRefPubMed
22.
go back to reference Meller J, Sahlmann CO, Sheel AK: 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007, 48: 35-45.PubMed Meller J, Sahlmann CO, Sheel AK: 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007, 48: 35-45.PubMed
23.
go back to reference Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan SL, Gibson R, Breuning M, Peters D, Ravine D: Unified Criteria for Ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009, 20: 205-212. 10.1681/ASN.2008050507.CrossRefPubMedPubMedCentral Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan SL, Gibson R, Breuning M, Peters D, Ravine D: Unified Criteria for Ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009, 20: 205-212. 10.1681/ASN.2008050507.CrossRefPubMedPubMedCentral
24.
go back to reference Alam A, Perrone RD: Managing Cyst Infections in ADPKD: An old problem looking for new answers. Clin J Am Soc Nephrol. 2009, 4: 1154-1155. 10.2215/CJN.03270509.CrossRefPubMed Alam A, Perrone RD: Managing Cyst Infections in ADPKD: An old problem looking for new answers. Clin J Am Soc Nephrol. 2009, 4: 1154-1155. 10.2215/CJN.03270509.CrossRefPubMed
25.
go back to reference Piccoli GB, Arena V, Consiglio V, Depascale A, Deagostini MC: Positron emission tomography: a precious tool in the challenge of the infected cysts in ADPKD. NDT Plus. 2010, 3: 492-493. 10.1093/ndtplus/sfq104.PubMedPubMedCentral Piccoli GB, Arena V, Consiglio V, Depascale A, Deagostini MC: Positron emission tomography: a precious tool in the challenge of the infected cysts in ADPKD. NDT Plus. 2010, 3: 492-493. 10.1093/ndtplus/sfq104.PubMedPubMedCentral
Metadata
Title
Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series
Authors
Giorgina B Piccoli
Vincenzo Arena
Valentina Consiglio
Maria Chiara Deagostini
Ettore Pelosi
Anastasios Douroukas
Daniele Penna
Giancarlo Cortese
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2011
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-12-48

Other articles of this Issue 1/2011

BMC Nephrology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.